Welcome
Our number one goal is providing shareholders and potential investors
with the information they need. Our Investor Relations Center is
provided to give you convenient access to company information, including financial reports, press
releases and corporate events.
If you are not successful finding the information you are looking
for on our website, please let us know, and we will do our best
to accommodate your request.
 Downloadable Nventa Fact Sheet
Nventa Biopharmaceuticals Investor Relations Contact Information
Donna Slade
Director of Investor Relations
Phone: (858) 202-4900
dslade@nventacorp.com
Request an investor infomation
package.
Awards:
Nventa is the Bronze Winner in the Biotechnology Division (up to $100MM market cap) of the LACP Annual Report Competition an international competition with 1,967 entries.
Stock Quote disclaimer:
The stock information shown on this site is provided by the Toronto Stock
Exchange and is delayed at least 15 minutes. Please note that current
price performance is not necessarily indicative of future price.
|
